News in the Life Sciences Industry

DURHAM, N.C., Jan. 17, 2020 /PRNewswire/ -- Alcami Corporation ("Alcami"), a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biologics industries, today announced it has acquired TriPharm Services ("TriPharm"), a new state-of-the-art sterile fill-finish... Read more ››

SAN FRANCISCO, Jan. 17, 2020 /PRNewswire/ -- AMPEL BioSolutions' Co-Founder and COO/CSO Dr. Amrie Grammer today at the Biotech Showcase at JP Morgan Healthcare announces the kickoff of a Series A $12.5M raise to commercialize LuGENE(TM), a gene-based diagnostic. AMPEL's initial focus is Lupus,... Read more ››

DUBLIN, Jan. 17, 2020 /PRNewswire/ -- The Read more ››

MONMOUTH JUNCTION, N.J., Jan. 17, 2020 /PRNewswire/ -- The American Professional Society of ADHD and Related Disorders (APSARD) is a U.S.-based international organization of health professionals and scientists focusing exclusively on ADHD and related disorders and Tris Pharma, Inc. ("Tris"),... Read more ››

MARIETTA, Ga., Jan. 17, 2020 /PRNewswire/ -- HTL-STREFA, a leading medical device company belonging to MTD Group (www.mtdglobal.com),... Read more ››

DUBLIN, Jan. 17, 2020 /PRNewswire/ -- The Read more ››

GERMANTOWN, Md., Jan. 17, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq:SNCA), a clinical-stage biopharmaceutical company developing novel treatments for various diseases of high unmet medical need, today announced the agreement by several accredited investors to exercise certain warrants... Read more ››

NUTLEY, N.J., Jan. 17, 2020 /PRNewswire/ -- Genomic medicine's groundbreaking treatments, and its future promise, will be the focus of a full-day symposium at the Hackensack Meridian Health Center for Discovery and Innovation (CDI) on Wednesday, February 19.

SANFORD, N.C., Jan. 16, 2020 /PRNewswire/ -- DisposeRx, Inc. has received its first patent from the US Patent and Trademark Office.... Read more ››

SAN FRANCISCO, Jan. 16, 2020 /PRNewswire/ -- Eric Hobbs, Ph.D., CEO of Berkeley Lights, spoke at the annual J.P. Morgan Healthcare Conference on Tuesday to a fully-packed room of industry leaders and the investment community about Berkeley Lights' technology, vision for the future, and upcoming... Read more ››

SILVER SPRING, Md., Jan. 16, 2020 /PRNewswire/ -- On Jan. 11 and again on Jan. 15, 2020, medical device manufacturer Cardinal Health alerted its customers to potential quality issues affecting some of its Level 3 surgical gowns and PreSource procedural packs that contain these gowns. Cardinal... Read more ››

WASHINGTON, Jan. 16, 2020 /PRNewswire/ -- MCRA, LLC, is a leading clinical research organization (CRO) and advisory firm specializing in medical devices and biologics. Its integration of regulatory, clinical research, reimbursement, compliance, and quality assurance assists companies in bringing... Read more ››

JERUSALEM, Jan. 16, 2020 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a Phase 3 clinical stage biopharmaceutical company focused on developing and commercializing M-001, a universal flu vaccine candidate, announced that effective January 16, 2020, the Company will permit holders... Read more ››

INDIANAPOLIS, Jan. 16, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter and full-year 2019 financial results on Thursday, January 30, 2020. Lilly will also conduct a conference call on that day with the investment community and media to further detail the... Read more ››

NEW YORK, Jan. 16, 2020 /PRNewswire/ -- (RED), the AIDS organization founded by Bono and Bobby Shriver, announced today the appointment of Jennifer Lotito to the position of President, effective immediately.

NEW YORK, Jan. 16, 2020 /PRNewswire/ -- Spheryx announces a poster presentation entitled "Quantitative Differentiation of Protein Aggregates from Subvisible Contaminants in Viscous Mixtures Through Holographic Characterization," delivered by Dr. Laura Philips, Spheryx President and CEO, on January... Read more ››

PLAINSBORO, N.J., Jan. 16, 2020 /PRNewswire/ -- Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Ozempic(®) (semaglutide) injection 0.5 mg or 1 mg to reduce the risk of major adverse cardiovascular events (MACE) such as... Read more ››